TECH
Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
$72.12
+0.06% today
Updated 2026-09-11
Market cap
$11.34B
P/E ratio
62.34
P/S ratio
9.33x
EPS (TTM)
$1.16
Dividend yield
0.44%
52W range
$43 – $73
Volume
3.3M
Bio-Techne Corp (TECH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$72.12
12-Month target
$11.32
2030 Target
—
Intrinsic (DCF)
$197.11
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 15.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.